222 related articles for article (PubMed ID: 31232197)
1. Efficacy and toxicity of sorafenib in patients with adenoid cystic carcinoma of the head and neck: a case series of five patients.
Couvreur K; Celine J; Marlies B; Randal D; Philippe D; Frederic D; Sylvie R
Acta Clin Belg; 2020 Oct; 75(5):362-369. PubMed ID: 31232197
[TBL] [Abstract][Full Text] [Related]
2. Clinical trial of nintedanib in patients with recurrent or metastatic salivary gland cancer of the head and neck: A multicenter phase 2 study (Korean Cancer Study Group HN14-01).
Kim Y; Lee SJ; Lee JY; Lee SH; Sun JM; Park K; An HJ; Cho JY; Kang EJ; Lee HY; Kim J; Keam B; Kim HR; Lee KE; Choi MY; Lee KH; Ahn MJ
Cancer; 2017 Jun; 123(11):1958-1964. PubMed ID: 28102887
[TBL] [Abstract][Full Text] [Related]
3. A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impact.
Locati LD; Perrone F; Cortelazzi B; Bergamini C; Bossi P; Civelli E; Morosi C; Lo Vullo S; Imbimbo M; Quattrone P; Dagrada GP; Granata R; Resteghini C; Mirabile A; Alfieri S; Orlandi E; Mariani L; Saibene G; Pilotti S; Licitra L
Eur J Cancer; 2016 Dec; 69():158-165. PubMed ID: 27821319
[TBL] [Abstract][Full Text] [Related]
4. Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors.
Wong SJ; Karrison T; Hayes DN; Kies MS; Cullen KJ; Tanvetyanon T; Argiris A; Takebe N; Lim D; Saba NF; Worden FP; Gilbert J; Lenz HJ; Razak AR; Roberts JD; Vokes EE; Cohen EE
Ann Oncol; 2016 Feb; 27(2):318-23. PubMed ID: 26598548
[TBL] [Abstract][Full Text] [Related]
5. Phase II trial of sorafenib in advanced salivary adenoid cystic carcinoma of the head and neck.
Thomson DJ; Silva P; Denton K; Bonington S; Mak SK; Swindell R; Homer J; Sykes AJ; Lee LW; Yap BK; Slevin NJ
Head Neck; 2015 Feb; 37(2):182-7. PubMed ID: 24346857
[TBL] [Abstract][Full Text] [Related]
6. [Chemotherapy with paclitaxel for lung metastases of cystic adenoid carcinoma. A case report and review of the literature].
Perrot E; Davy N; Poubeau P; Arvin-Berod C
Rev Pneumol Clin; 2003 Dec; 59(6):371-4. PubMed ID: 14745344
[TBL] [Abstract][Full Text] [Related]
7. Patients with adenoid cystic carcinomas of the salivary glands treated with lenvatinib: Activity and quality of life.
Locati LD; Galbiati D; Calareso G; Alfieri S; Singer S; Cavalieri S; Bergamini C; Bossi P; Orlandi E; Resteghini C; Platini F; Granata R; Quattrone P; Mancinelli M; Mariani L; Lo Vullo S; Licitra LF
Cancer; 2020 Jan; 126(9):1888-1894. PubMed ID: 32031693
[TBL] [Abstract][Full Text] [Related]
8. Rare breast metastasis from adenoid cystic carcinoma of the submandibular gland.
Krucoff KB; Shammas RL; Stoecker M; Tolnitch LA
BMJ Case Rep; 2018 Aug; 2018():. PubMed ID: 30068574
[TBL] [Abstract][Full Text] [Related]
9. Phase II study of lapatinib in recurrent or metastatic epidermal growth factor receptor and/or erbB2 expressing adenoid cystic carcinoma and non adenoid cystic carcinoma malignant tumors of the salivary glands.
Agulnik M; Cohen EW; Cohen RB; Chen EX; Vokes EE; Hotte SJ; Winquist E; Laurie S; Hayes DN; Dancey JE; Brown S; Pond GR; Lorimer I; Daneshmand M; Ho J; Tsao MS; Siu LL
J Clin Oncol; 2007 Sep; 25(25):3978-84. PubMed ID: 17761983
[TBL] [Abstract][Full Text] [Related]
10. Distant metastases of adenoid cystic carcinoma of the salivary glands and the value of diagnostic examinations during follow-up.
van der Wal JE; Becking AG; Snow GB; van der Waal I
Head Neck; 2002 Aug; 24(8):779-83. PubMed ID: 12203804
[TBL] [Abstract][Full Text] [Related]
11. Activating NOTCH1 Mutations Define a Distinct Subgroup of Patients With Adenoid Cystic Carcinoma Who Have Poor Prognosis, Propensity to Bone and Liver Metastasis, and Potential Responsiveness to Notch1 Inhibitors.
Ferrarotto R; Mitani Y; Diao L; Guijarro I; Wang J; Zweidler-McKay P; Bell D; William WN; Glisson BS; Wick MJ; Kapoun AM; Patnaik A; Eckhardt G; Munster P; Faoro L; Dupont J; Lee JJ; Futreal A; El-Naggar AK; Heymach JV
J Clin Oncol; 2017 Jan; 35(3):352-360. PubMed ID: 27870570
[TBL] [Abstract][Full Text] [Related]
12. A phase II study of sunitinib in recurrent and/or metastatic adenoid cystic carcinoma (ACC) of the salivary glands: current progress and challenges in evaluating molecularly targeted agents in ACC.
Chau NG; Hotte SJ; Chen EX; Chin SF; Turner S; Wang L; Siu LL
Ann Oncol; 2012 Jun; 23(6):1562-70. PubMed ID: 22080184
[TBL] [Abstract][Full Text] [Related]
13. A phase II study of Imatinib for advanced adenoid cystic carcinoma of head and neck salivary glands.
Pfeffer MR; Talmi Y; Catane R; Symon Z; Yosepovitch A; Levitt M
Oral Oncol; 2007 Jan; 43(1):33-6. PubMed ID: 16757202
[TBL] [Abstract][Full Text] [Related]
14. Response to paclitaxel in adenoid cystic carcinoma of the salivary glands.
Till BG; Martins RG
Head Neck; 2008 Jun; 30(6):810-4. PubMed ID: 17979110
[TBL] [Abstract][Full Text] [Related]
15. Phase II study of cisplatin and imatinib in advanced salivary adenoid cystic carcinoma.
Ghosal N; Mais K; Shenjere P; Julyan P; Hastings D; Ward T; Ryder WD; Bruce I; Homer J; Slevin NJ
Br J Oral Maxillofac Surg; 2011 Oct; 49(7):510-5. PubMed ID: 21071117
[TBL] [Abstract][Full Text] [Related]
16. Tamoxifen for salivary gland adenoid cystic carcinoma: report of two cases.
Elkin AD; Jacobs CD
J Cancer Res Clin Oncol; 2008 Oct; 134(10):1151-3. PubMed ID: 18347813
[TBL] [Abstract][Full Text] [Related]
17. Lung metastasis resection of adenoid cystic carcinoma of salivary glands.
Bobbio A; Copelli C; Ampollini L; Bianchi B; Carbognani P; Bettati S; Sesenna E; Rusca M
Eur J Cardiothorac Surg; 2008 May; 33(5):790-3. PubMed ID: 18343149
[TBL] [Abstract][Full Text] [Related]
18. Phase II study of gefitinib in patients with advanced salivary gland cancers.
Jakob JA; Kies MS; Glisson BS; Kupferman ME; Liu DD; Lee JJ; El-Naggar AK; Gonzalez-Angulo AM; Blumenschein GR
Head Neck; 2015 May; 37(5):644-9. PubMed ID: 24585506
[TBL] [Abstract][Full Text] [Related]
19. Phase II trial with axitinib in recurrent and/or metastatic salivary gland cancers of the upper aerodigestive tract.
Locati LD; Cavalieri S; Bergamini C; Resteghini C; Alfieri S; Calareso G; Bossi P; Perrone F; Tamborini E; Quattrone P; Granata R; Galbiati D; Platini F; Orlandi E; Mariani L; Licitra L
Head Neck; 2019 Oct; 41(10):3670-3676. PubMed ID: 31355973
[TBL] [Abstract][Full Text] [Related]
20. Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review.
Laurie SA; Ho AL; Fury MG; Sherman E; Pfister DG
Lancet Oncol; 2011 Aug; 12(8):815-24. PubMed ID: 21147032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
